|
AD Connect
User
Home
ADDI Announcements
Forums
AD Workbench Tech Help
Help
FAQ
Events
Video Library
Register Now
Datasets
A Phase 2a Study
More
Cancel
New
A Phase 2a Study
Description
A forum to discuss or ask questions about a Phase 2a Study to Evaluate the Effect of Rilapladib (SB-659032) on Biomarkers Related to the Pathogenesis and Progression of Alzheimer's Disease
Threads
1 Discussion
Frequently Asked
ADDI's Editorial Take
2 months ago
Tags
RSS
More
Cancel
By title
By last reply date
By thread date
By reply count
By view count
By most asked
By votes
By quality
Descending
Ascending
All recent questions and discussions
Unanswered questions and discussions
Answered questions and discussions
Questions with suggested answers
Questions and discussions with no replies
Not Answered
ADDI's Editorial Take
0
56
views
0
replies
Started
2 months ago
by
Sebastian Ford
